The company said its Board appointed Quentin Blackford, 48, as a director on August 27, 2026 and increased the size of the Board from 10 to 11 directors as a result.

1. 01

   The company said its Board appointed Quentin Blackford, 48, as a director on August 27, 2026 and increased the size of the Board from 10 to 11 directors as a result.

2. 02

   The company said Mr. Blackford will participate in the non-employee director compensation program, except that the annual retainer and equity grant will be prorated for his service from his appointment date until the 2027 annual meeting of stockholders. It also said it expects him to stand for election at the next annual meeting, which is expected to be held in May 2027.

3. 03

   The company said Andrea L. Saia notified the Board on August 27, 2026 that she will resign as a director effective September 23, 2026. The company said her decision to resign is not because of any disagreement with the company on matters relating to its operations, policies or practices, and that she was not removed for cause.

4. 04

   The company said the Board size will decrease from 11 to 10 directors upon Ms. Saia's resignation, effective immediately. It also said Mr. Blackford has served as President and Chief Executive Officer of iRhythm Technologies since 2021 and previously served as Chief Operating Officer of Dexcom.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.